Ecstasy: Neurotoxicity and How It Can Be Reduced

Ecstasy: Neurotoxicity and how it reduces the vagus nerve (MDMA) is the optimal drug for children aged 18-25 (2), the impact on behavior and neurotoxicity is noteworthy for this course . The use of ecstasy is common not only at the university campus but also at the venues of carnival and night clubs. In this article we will explore how users can mitigate the risk of using MDMA's mechanism of action, its neurotoxicity, and ecstasy. Ecstasy changes behavior by raising the level of serotonin in the brain.

Other ecstasy-like drugs such as MDA (methylenedioxyamphetamine, ecstasy parent drug) and PMA (p-methoxyamphetamine, related to deaths in the United States and Australia) may be sold as ecstasy. These drugs are neurotoxic or may pose additional health risks to the user. In addition to ecstasy, ecstasy may be contaminated with other substances such as ephedrine (stimulant), dextromethorphan (DXM, cough suppressant showing high PCP-like effect at high dose), ketamine (major) not. Anesthetics used by veterinarians are also effective like PCP; caffeine; cocaine; and methamphetamine

The effect of ecstasy is devastating to the body. The ecstasy effect can cause pain in the heart and body of the user seeking ecstasy. The pleasant ecstasy effect includes a relaxed mood, feeling, relief of anxiety, a high sensitivity to other people, and a high energy level lasting several hours. The negative impact of ecstasy far outweighs profits. Ecstasy causes confusion, sleep disturbance, anxiety, blurred vision, hemorrhoids, brain injury, depression, poisoning, paranoia, nausea, liver injury and aggression. In addition to these results, memory impairment and the long-term reduction of serotonin and dopamine may disrupt ecstasy users' normal brain activity, causing learning disabilities and mental problems. Unstable mood swings and depression can lead to isolation from friends and family (MDMA n.pag)